FDA Gives Amneal's Generic Alzheimer’s & Parkinson’s Patch a Thumbs-Up

FDA Gives Amneal's Generic Alzheimer’s & Parkinson’s Patch a Thumbs-Up

Source: 
BioSpace
snippet: 

The U.S. Food and Drug Administration (FDA) approved Bridgewater, NJ-based Amneal Pharmaceuticals’ generic version of Novartis’ Exelon Patch (Rivastigmine Transdermal System) for dementia related to Alzheimer’s and Parkinson’s diseases.